Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 5
2017 9
2018 14
2019 7
2020 15
2021 16
2022 7
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Programming cytomegalovirus as an HIV vaccine.
Picker LJ, Lifson JD, Gale M Jr, Hansen SG, Früh K. Picker LJ, et al. Trends Immunol. 2023 Apr;44(4):287-304. doi: 10.1016/j.it.2023.02.001. Epub 2023 Mar 7. Trends Immunol. 2023. PMID: 36894436 Free PMC article. Review.
Zika virus vaccines.
Abbink P, Stephenson KE, Barouch DH. Abbink P, et al. Nat Rev Microbiol. 2018 Oct;16(10):594-600. doi: 10.1038/s41579-018-0039-7. Nat Rev Microbiol. 2018. PMID: 29921914 Free PMC article. Review.
Prospects for a Zika Virus Vaccine.
Barouch DH, Thomas SJ, Michael NL. Barouch DH, et al. Immunity. 2017 Feb 21;46(2):176-182. doi: 10.1016/j.immuni.2017.02.005. Immunity. 2017. PMID: 28228277 Free PMC article. Review.
Neutralizing antibodies for HIV-1 prevention.
Julg B, Barouch DH. Julg B, et al. Curr Opin HIV AIDS. 2019 Jul;14(4):318-324. doi: 10.1097/COH.0000000000000556. Curr Opin HIV AIDS. 2019. PMID: 31082819 Free PMC article. Review.
Immune Correlate-Guided HIV Vaccine Design.
Alter G, Barouch D. Alter G, et al. Cell Host Microbe. 2018 Jul 11;24(1):25-33. doi: 10.1016/j.chom.2018.06.012. Cell Host Microbe. 2018. PMID: 30001521 Free PMC article. Review.
Approaches and Challenges in SARS-CoV-2 Vaccine Development.
Dagotto G, Yu J, Barouch DH. Dagotto G, et al. Cell Host Microbe. 2020 Sep 9;28(3):364-370. doi: 10.1016/j.chom.2020.08.002. Epub 2020 Aug 10. Cell Host Microbe. 2020. PMID: 32798444 Free PMC article. Review.
New concepts in HIV-1 vaccine development.
Stephenson KE, D'Couto HT, Barouch DH. Stephenson KE, et al. Curr Opin Immunol. 2016 Aug;41:39-46. doi: 10.1016/j.coi.2016.05.011. Epub 2016 Jun 3. Curr Opin Immunol. 2016. PMID: 27268856 Free PMC article. Review.
Therapeutic efficacy of combined active and passive immunization in ART-suppressed, SHIV-infected rhesus macaques.
Walker-Sperling VEK, Mercado NB, Chandrashekar A, Borducchi EN, Liu J, Nkolola JP, Lewis M, Murry JP, Yang Y, Geleziunas R, Robb ML, Michael NL, Pau MG, Wegmann F, Schuitemaker H, Fray EJ, Kumar MR, Siliciano JD, Siliciano RF, Barouch DH. Walker-Sperling VEK, et al. Nat Commun. 2022 Jun 16;13(1):3463. doi: 10.1038/s41467-022-31196-5. Nat Commun. 2022. PMID: 35710819 Free PMC article.
Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial.
Stephenson KE, Julg B, Tan CS, Zash R, Walsh SR, Rolle CP, Monczor AN, Lupo S, Gelderblom HC, Ansel JL, Kanjilal DG, Maxfield LF, Nkolola J, Borducchi EN, Abbink P, Liu J, Peter L, Chandrashekar A, Nityanandam R, Lin Z, Setaro A, Sapiente J, Chen Z, Sunner L, Cassidy T, Bennett C, Sato A, Mayer B, Perelson AS, deCamp A, Priddy FH, Wagh K, Giorgi EE, Yates NL, Arduino RC, DeJesus E, Tomaras GD, Seaman MS, Korber B, Barouch DH. Stephenson KE, et al. Nat Med. 2021 Oct;27(10):1718-1724. doi: 10.1038/s41591-021-01509-0. Epub 2021 Oct 7. Nat Med. 2021. PMID: 34621054 Free PMC article. Clinical Trial.
77 results